For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatru/Cagrilintide is a dual-compound research peptide combining Retatru, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog
Bottom line: A routine built on bioavailable NAD+ and Glutathione support helps address energy, repair, and protection simultaneously
Pain flares up after activity Just as you might experience pain after standing still, intense activity may also cause pain to flare up
Havent lost any weight per say I inject myself twice a week watch what I eat why am I not losing weight